Streptomycin sulphate is frequently administered routinely as a primary drug in the treatment of pulmonary tuberculosis. The serious ototoxic effects of this drug which occasionally develop are related to the dosage, blood concentration, age of the patient, and renal function. Clustering of untoward reactions within families treated with conventional doses of streptomycin has been noted and in some instances this predisposition has apparently been inherited. '-3 We have investigated a large kindred in which eight persons developed severe perceptive deafness during antituberculous therapy with parenterally administered streptomycin sulphate. Our findings are presented and discussed in this paper in order to support the concept of a rare autosomal gene which confers a high risk for a dominant phenotype of permanent perceptive deafness upon exposure to conventional treatment with streptomycin.
Investigation, subjects, and methods A large non-consanguineous family of mixed ancestry in which several persons had deafness that was related to antituberculous therapy was seen in a peripheral genetic clinic. The kindred consisted of persons of social class V and numerous members had suffered from pulmonary tuberculosis.
The Two patterns of symptomatology were evident with ototoxic features presenting within one week of the start of treatment in patients 1 and 5, and only after 1 to 5 months in the remainder. No subject complained of vertigo, but five persons experienced tinnitus with simultaneous onset of deafness.
An adolescent girl (IV. 1), who was ostensibly deaf and who had received only prophylactic tuberculous therapy with isoniazid 300 mg daily, was found to be malingering and to have normal hearing. She had previously convinced another institution of her hearing loss and had been issued with a hearing aid which she never used.
Discussion
The ototoxic complications of all the aminoglycoside antibiotics are well known and similar. The mechanism of ototoxicity at a molecular level is unclear but Spoendlin,4 in electron microscopic studies of the inner ears of cats, showed that the aminoglycoside antibiotics may act in a manner akin to their antimicrobial action by inhibiting protein synthesis. In animal investigations, Kehonen5 and Engstrom and Kehonen6 recognised primary damage by streptomycin to the organ of Corti hair cells followed secondarily by the involvement of the nerve fibres and ganglion cells. This process, which is dose related, has been confirmed in human studies.7
The type of deafness in our patients is perceptive and is localised to the end organ (cochlea) as confirmed by audiometry. Also 
